Abstract
Author details Surgery, the Affiliated Hospital of Medical College, QingDao University, QingDao 266003, R. P. China. Pathology, the Affiliated Hospital of Medical College, QingDao University, QingDao, Shan Dong Province 266003, P. R. China. Molecular Biology, the Affiliated Hospital of Medical College, QingDao University, QingDao, Shan Dong Province 266003, P. R. China. Hepatobiliary surgery, Tianjin Medical University Cancer Institute and Hospital, Huanhuxi Road, Hexi District, Tianjin 300060, China. Key Laboratory of Cancer Prevention and Therapy, Tianjin, China. Department of Surgery, the Affiliated Hospital of Medical College, QingDao University, No 16 Jiangsu Road, Qingdao, Shan Dong Province 266003, P. R. China.
Highlights
Convenient online submission Thorough peer review No space constraints or color figure charges Immediate publication on acceptance Inclusion in PubMed, CAS, Scopus and Google Scholar Research which is freely available for redistribution
We apologise to the readers and OncoGenex Technologies for this oversight and any negative effects that may have resulted from it
Research which is freely available for redistribution
Summary
Correction: Clusterin confers gemcitabine resistance in pancreatic cancer Qingfeng Chen1†, Zhengkun Wang1†, Kejun Zhang1†, Xiaoyi Liu1, Weihong Cao2, Lei Zhang3, Shuhua Zhang1, Bomin Yan1,6*, Yaoguang Wang4,5 and Chunping Xia4,5 Correction After the publication of this work [1], we noticed that we had incorrectly used the term ‘OGX-011’.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
